Biotech News
MIMEDX Announces Record Fourth Quarter and Full Year 2025 Operating and Financial Results
mimedx.gcs-web.com2026-05-06 14:56 EST
Net Sales Grew 27% Year-Over-Year for the Fourth Quarter and 20% for the Full Year Fourth Quarter GAAP Net Income and Earnings Per Share were $15 million and $0.10, Respectively Fourth Quarter Adjusted EBITDA 1 was $29 Million, or 25% of Net Sales Company Estimates 2026 Net Sales in a Range of